Page last updated: 2024-08-18

pyrazolanthrone and Squamous Cell Carcinoma of Head and Neck

pyrazolanthrone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badarni, M; Balaban, N; Cohen, L; Dinur, AB; Elkabets, M; Grénman, R; Joshua, BZ; Prasad, M; Rotblat, B; Yegodayev, KM; Zorea, J	1

Other Studies

1 other study(ies) available for pyrazolanthrone and Squamous Cell Carcinoma of Head and Neck

Article	Year
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy. JCI insight, 2019, 03-12, Volume: 5 Topics: Animals; Anthracenes; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Tongue; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Xenograft Model Antitumor Assays	2019

Article

Year

Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.

JCI insight, 2019, 03-12, Volume: 5

Topics: Animals; Anthracenes; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Squamous Cell Carcinoma of Head and Neck; Thiazoles; Tongue; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Xenograft Model Antitumor Assays

2019